Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes was up 5.4% year on year. At €666.37 Per Capita in 2019, the country was ranked number 1 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 666.37 |
2018 | 645.99 |
2017 | 652.37 |
2016 | 635.56 |
2015 | 615.94 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
# | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data |
2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data |
3 |
#3
Liechtenstein
|
527.16 | 2019 | +3.4 % | +0.9 % | View data |
4 |
#4
Ireland
|
447.21 | 2019 | -0.8 % | +2.1 % | View data |
5 |
#5
Belgium
|
429.86 | 2019 | +0.5 % | +4.4 % | View data |